Apollo Global Management
APO
$110.78
-0.97%
Apollo Global Management is one of the world's largest alternative asset managers, operating two core segments: a credit-heavy asset management franchise (roughly $849 billion of its $1.047 trillion in total AUM sits in credit, with smaller private equity and real assets books) and a retirement services platform anchored by its Athene annuity business, which now generates the majority of consolidated revenue. Apollo's distinctive identity rests on its 'origination-first' credit engine and its integration of insurance liabilities with private credit, a model that differentiates it from pure-play managers like Blackstone and KKR and gives it a structural funding advantage. The current investor debate centers on whether that model can keep compounding fee-earning AUM (now $858 billion) through the opening of private credit to 401(k) plans, while digesting the earnings volatility from mark-to-market swings in the retirement segment and the capital deployment implied by large deals such as the reported $7.7 billion bid for easyJet. Sentiment has soured materially in 2026, with the stock down sharply year-to-date amid a broad de-rating of alternative managers, even as sell-side analysts remain overwhelmingly constructive on the franchise.…
APO
Apollo Global Management
$110.78
Related headlines
Investment Opinion: Should I buy APO Today?
Rating: Buy (accumulate on stabilization). The core thesis is that Apollo's 10.4x forward PE and 9.1% free cash flow yield price in a permanent earnings-quality discount that the 20-analyst buy consensus (mean 1.77) and $149.40 average target (34.9% upside) do not support, even as the stock sits only 11% above its 52-week low. The franchise, with $858 billion of fee-earning AUM and a structural private-credit-to-401(k) tailwind, is not deteriorating at the rate the -24.4% year-to-date decline implies.
Supporting evidence: the forward PE of 10.4x on consensus EPS of $13.42 is near the low end of Apollo's two-year quarterly band (11.8x-50.3x) and roughly 60% below the 25.9x trailing multiple; Q2 2026 revenue grew 64.5% year-over-year to $11.209 billion with a 12.1% net margin; trailing free cash flow of $7.987 billion yields about 9.1% and covers the 1.47% dividend at a 37.2% payout ratio; and even the lowest analyst target of $127 implies 14.7% upside. Price-to-book at 3.77x is below the 4.3x-5.6x levels seen in mid-2024 through early 2025, consistent with de-rating rather than fundamental deterioration.
The biggest risks that could invalidate the thesis are a recurrence of mark-to-market losses like Q1 2026's $1.906 billion net loss, a decisive break below the $99.56 52-week low that triggers momentum selling, and capital deployment such as the $7.7 billion easyJet bid that consumes balance-sheet capacity without clear returns. The rating would upgrade to a stronger Buy if the stock establishes a higher low above $120 and Q3 operating margin recovers above 25%, and would downgrade to Hold if revenue growth decelerates below 20% or the current ratio falls further below 0.78. Verdict: undervalued relative to its own forward-PE history and to the analyst consensus, but fairly valued to slightly expensive on trailing earnings until the mark-to-market noise clears.
Sign up to view all
APO 12-Month Price Forecast
The forward valuation is compelling at 10.4x earnings against a franchise with $858 billion of fee-earning AUM and a 9.1% free cash flow yield, and the sell-side consensus of $149.40 with no target below the current price is a powerful signal that the sell-off is overdone. But the technical picture is unambiguously negative, with the stock in an accelerating downtrend, 36.4 points behind the S&P 500 year-to-date, and only 11% above its 52-week low, while the Q1 2026 net loss of $1.906 billion shows earnings quality remains hostage to mark-to-market swings. The balanced stance reflects this tension: the fundamental case supports accumulation, but the price action argues for waiting for a higher low before committing capital. I would upgrade to bullish on a reclaim of the $120-$125 resistance zone with a Q3 earnings beat and margin recovery above 25%, and downgrade to bearish on a decisive break below $99.56 or another loss quarter.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Apollo Global Management's 12-month outlook, with a consensus price target around $149.40 and implied upside of +34.9% versus the current price.
Average Target
$149.40
0 analysts
Implied Upside
+34.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$127 - $173
Analyst target range
Coverage is deep and the consensus is firmly bullish. Twenty analysts cover Apollo with a consensus recommendation of 'buy' (mean rating of 1.77 on a scale where 1 is a strong buy), and the average target price of $149.40 implies roughly 34.9% upside from the current $110.78 — a wide gap that signals the sell-side views the recent sell-off as overdone. The consensus EPS estimate of $13.42 (range $13.04 to $13.80) and revenue estimate of $8.425 billion (range $8.239 billion to $8.607 billion) underpin that optimism, and the tightness of the EPS estimate range suggests high confidence in the near-term earnings trajectory. The bullish tilt is reinforced by institutional ratings: JP Morgan, UBS, Barclays, Morgan Stanley, and Piper Sandler all carry Overweight/Buy ratings, with no downgrades in the recent tape — the most recent actions (September 2 and August 5) were reiterations rather than cuts. The target range of $127.00 to $173.00 is wide — the high target is 36% above the low — which signals meaningful disagreement about the earnings recovery and multiple expansion path. The $173 high likely assumes a normalization of mark-to-market results, continued fee-earning AUM growth toward and beyond $858 billion, and a re-rating toward historical forward multiples in the mid-teens or higher; the $127 low still implies about 14.7% upside and appears to price in persistent spread compression, muted capital deployment returns, and a discount for the retirement segment's earnings volatility. Notably, even the lowest analyst target sits above the current price, a rare configuration that underscores how far sentiment has detached from fundamental coverage — though investors should weigh that against the stock's 1.58 beta and 8.62 short ratio, which suggest the path to consensus could remain volatile.
Bulls vs Bears: APO Investment Factors
The bear case currently has stronger near-term evidence: the stock is in a confirmed downtrend (-24.4% YTD, -36.4 points of relative strength versus the S&P 500), sits only 11% above its 52-week low, and carries elevated earnings volatility from the retirement segment's mark-to-market swings. The bull case rests on valuation and consensus: a 10.4x forward PE, a 9.1% free cash flow yield, 64.5% Q2 revenue growth, and an average analyst target of $149.40 (34.9% upside) with not a single target below the current price. The single most important tension is whether Apollo's GAAP earnings volatility is a temporary mark-to-market artifact masking a durable fee-compounding machine, or a structural feature of the insurance-linked model that deserves a permanently lower multiple. If fee-related earnings and spread income normalize as the sell-side expects (consensus EPS of $13.42), the stock is deeply undervalued; if mark-to-market swings persist and the easyJet-style capital deployment consumes balance-sheet capacity, the de-rating has further to run.
Bullish
- Deep analyst consensus with 34.9% upside: All 20 covering analysts rate APO a buy (mean 1.77), and even the lowest target of $127 sits 14.7% above the $110.78 price, while the $149.40 average implies 34.9% upside. The tight EPS estimate range of $13.04-$13.80 signals high confidence in the near-term earnings recovery.
- Forward PE of 10.4x is historically cheap: The forward PE of 10.4x on consensus EPS of $13.42 is near the low end of Apollo's two-year quarterly PE band (11.8x-50.3x) and roughly 60% below the 25.9x trailing multiple. For a franchise with $858 billion of fee-earning AUM, that multiple embeds substantial skepticism about earnings quality rather than franchise deterioration.
- Fee-earning AUM compounding at scale: Fee-earning AUM reached $858.0 billion of the $1.047 trillion total, with credit alone at $849.3 billion total and $754.1 billion fee-earning. The opening of the $14 trillion 401(k) market to private credit is a structural tailwind that directly feeds Apollo's origination-first credit engine.
- 9.1% free cash flow yield funds dividend: Trailing free cash flow of $7.987 billion against an $88.0 billion market cap yields roughly 9.1%, comfortably covering the 1.47% dividend (37.2% payout ratio). Q2 2026 operating cash flow of $3.245 billion shows the core engine still generates cash through the drawdown.
Bearish
- Severe relative-strength breakdown: APO is down 24.4% year-to-date versus the S&P 500's +11.9%, a -36.4 percentage point relative-strength gap, and -12.3 points over the past month alone. At $110.78 the stock sits at just 20.6% of its 52-week range ($99.56-$153.29), only 11% above the low, with a 34.3% max drawdown.
- Earnings volatility from insurance marks: Q1 2026 produced a $1.906 billion net loss and -$3.24 diluted EPS, dragging trailing EPS to $0.04 and the trailing PE to 25.9x. Quarterly revenue has swung from $5.057 billion (Q1 2026) to $11.209 billion (Q2 2026) versus $9.864 billion in Q4 2025, making GAAP earnings an unreliable guide to the business.
- Margin compression versus prior quarters: Q2 2026 operating margin of 23.2% compares with 32.3% in Q3 2025 and 36.4% in Q4 2024, while the quarterly gross margin of 60.8% reflects the lower-margin retirement spread income mix versus the 95.5% company-level fee margin. If spread income keeps growing faster than fee income, consolidated margins stay under pressure.
- Thin liquidity and balance-sheet funding: The current ratio of 0.78 means current liabilities exceed current assets, and Q2 investing outflows of $15.2 billion plus $28.7 billion of Q1 investment purchases show growth is funded through balance-sheet deployment and external financing. Debt-to-equity of 0.57x and total debt to capitalization of 39.5% leave less room if marks turn adverse.
APO Technical Analysis
Apollo is in a clear, sustained downtrend. The stock has fallen 8.3% over the past year and 24.4% year-to-date, and at $110.78 it sits at just 20.6% of its 52-week range of $99.56 to $153.29 — a positioning that signals persistent distribution rather than a healthy pullback, and one that keeps the falling-knife risk elevated until a higher low is established. The 34.3% maximum drawdown underscores how far the stock has traveled from its highs, and the fact that the current price is only about 11% above the 52-week low means the margin of safety from a technical standpoint is thin. Momentum is deteriorating rather than stabilizing: the 1-month change of -11.0% is worse than the 3-month change of -8.0% and the 6-month change of -11.1%, indicating acceleration to the downside. This short-term weakness is also a stark divergence from the broader market, with relative strength of -12.3 percentage points versus the S&P 500 over one month and -36.4 points year-to-date, while the benchmark itself is up 1.2% and 11.9% over those same windows — a classic relative-strength breakdown that argues against bottom-fishing without a reversal signal. Key technical levels are well defined: the $99.56 52-week low is the line in the sand, and a decisive break below it would likely trigger further momentum-driven selling and open a new leg lower, while resistance sits at the $153.29 high, with intermediate supply likely clustered around the $120-$125 area where the stock repeatedly failed in September. With a beta of 1.58, Apollo is roughly 58% more volatile than the S&P 500, meaning position sizing should be scaled down accordingly and stops placed with wider bands to avoid noise-driven exits; the elevated short ratio of 8.62 days-to-cover also hints at meaningful bearish positioning that could fuel sharp squeezes on any positive catalyst.
Beta
1.58
1.58x market volatility
Max Drawdown
-34.3%
Largest decline past year
52-Week Range
$100-$153
Price range past year
Annual Return
-8.3%
Cumulative gain past year
| Period | APO Return | S&P 500 |
|---|---|---|
| 1m | -11.0% | +0.2% |
| 3m | -8.0% | +2.9% |
| 6m | -11.1% | +8.4% |
| 1y | -8.3% | +14.9% |
| ytd | -24.4% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
APO Fundamental Analysis
Apollo's top-line trajectory is strong but lumpy. Most recent quarterly revenue (Q2 2026, ended June 30) was $11.209 billion, up 64.5% year-over-year from $6.814 billion, driven overwhelmingly by the retirement services segment at $9.526 billion versus asset management at $1.627 billion. However, the sequential path is highly uneven — Q1 2026 revenue was just $5.057 billion (a quarter in which the company posted a net loss) versus $9.864 billion in Q4 2025 and $9.823 billion in Q3 2025 — reflecting the mark-to-market and spread-income volatility inherent in the insurance-linked model rather than a smooth compounding curve. The takeaway for investors is that headline growth is real but should be judged on fee-related earnings and spread income rather than GAAP revenue, which swings with markets. Profitability is solid at the operating line but noisy at the bottom line. Q2 2026 produced net income of $1.361 billion (a 12.1% net margin) on gross profit of $6.819 billion (60.8% gross margin) and operating income of $2.605 billion (23.2% operating margin), yet the trailing twelve-month picture is distorted by the Q1 2026 net loss of $1.906 billion, which dragged the reported EPS to just $0.04 and the trailing net margin to 10.9%. The company-level gross margin of 95.5% and operating margin of 25.8% in the valuation data reflect the fee-based asset management economics, while the quarterly 60.8% figure reflects the consolidation of lower-margin retirement spread income — a mix effect, not deterioration. The key question is whether margins can expand as fee-earning AUM scales; the Q2 operating margin of 23.2% versus 32.3% in Q3 2025 suggests some compression worth monitoring. The balance sheet is leveraged but manageable for the business model. Debt-to-equity stands at 0.57x with total debt to capitalization of 39.5%, and the company generated $7.987 billion in trailing free cash flow against a $88.0 billion market cap — a free cash flow yield of roughly 9.1%, which is attractive for a financial. Liquidity is the weak spot: the current ratio of 0.78 is below 1.0, meaning current liabilities exceed current assets, though for an insurer/asset manager with $28.4 billion in cash at the end of Q2 2026 this is less alarming than it would be for an industrial. ROE of 15.0% is respectable, and the $3.245 billion of Q2 operating cash flow comfortably covers the modest dividend (payout ratio 37.2%, yield 1.47%), but the heavy investing outflows — $15.2 billion in Q2 and $28.7 billion of investment purchases in Q1 — confirm that growth is being funded through balance-sheet deployment and external financing rather than purely internal cash generation.
Quarterly Revenue
$11.2B
2026-06
Revenue YoY Growth
+64.5%
YoY Comparison
Gross Margin
60.8%
Latest Quarter
Free Cash Flow
$8.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is APO Overvalued?
Because Apollo is profitable on a trailing basis (net income positive, EPS of $0.04), the PE ratio is the appropriate primary metric, though the trailing figure is distorted by the Q1 loss. The trailing PE of 25.9x collapses to a forward PE of just 10.4x based on consensus EPS of $13.42 for the coming year — a roughly 60% compression that tells you the market is either pricing in a dramatic earnings recovery or that the trailing number is unrepresentative of normalized earning power. Given the Q1 mark-to-market loss, the forward multiple is the more meaningful lens, and at 10.4x forward earnings Apollo looks inexpensive for a franchise growing fee-earning AUM at scale. On a price-to-sales basis, the 2.75x PS ratio and 2.31x EV/Sales are modest, while the 3.77x price-to-book and 9.69x EV/EBITDA sit in a reasonable range for an alternative manager with an insurance balance sheet. Peer comparison is constrained by the absence of an explicit industry-average multiple in the provided valuation data, but the internal spread is instructive: a 10.4x forward PE against a 25.9x trailing PE implies the market expects earnings to roughly 2.5x, and the negative PEG ratio of -1.06 reflects the trailing-earnings distortion rather than a genuine growth problem. Relative to the premium multiples alternative managers historically command (often 20x-30x forward earnings during growth phases), Apollo's 10.4x forward multiple represents a substantial discount that appears to embed skepticism about earnings quality and mark-to-market volatility rather than about the franchise itself. Historically, Apollo's own PE band has been wide: quarterly PE ratios in the provided data range from about 11.8x (Q3 2025) and 13.0x-13.1x (Q4 2025 and Q2 2026) up to 35.5x (Q2 2025) and 50.3x (Q1 2025), with the negative readings in Q1 2026 (-8.6x) reflecting the loss quarter. The current 25.9x trailing PE sits in the upper-middle of that range, but the 10.4x forward multiple is near the low end of the historical band — a divergence that suggests the market is pricing in optimistic near-term earnings recovery while the trailing multiple still reflects the depressed base. Price-to-book at 3.77x is mid-range versus the 3.3x-5.6x readings over the past two years, and notably below the 4.3x-5.6x levels seen in mid-2024 through early 2025, consistent with the de-rating rather than fundamental deterioration.
PE
25.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 5x~24x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on earnings quality and balance-sheet intensity. Q1 2026's $1.906 billion net loss and -$3.24 diluted EPS show how quickly mark-to-market moves can swing reported results, leaving trailing EPS at just $0.04 and the trailing PE at 25.9x despite a 10.4x forward multiple. The current ratio of 0.78 is below 1.0, and Q2 investing outflows of $15.2 billion alongside $28.7 billion of Q1 investment purchases confirm that growth depends on continued balance-sheet deployment and external financing rather than internal cash alone. Debt-to-equity of 0.57x and total debt to capitalization of 39.5% are manageable but leave less cushion if marks turn adverse, and the Q2 operating margin of 23.2% versus 32.3% in Q3 2025 shows the mix shift toward lower-margin retirement spread income is already compressing consolidated profitability.
Market and competitive risks are dominated by the de-rating of alternative managers and the stock's high sensitivity. With a beta of 1.58, APO is roughly 58% more volatile than the S&P 500, and its -36.4 percentage point year-to-date relative-strength gap versus a benchmark that is up 11.9% shows the market is actively rotating away from the name. The 8.62-day short ratio indicates meaningful bearish positioning that can amplify moves in either direction, and the reported $7.7 billion bid for easyJet at a 46% premium raises questions about capital discipline and deployment returns at a moment when investors are already skeptical. Competitive pressure in private credit is intensifying as the $14 trillion 401(k) channel opens, attracting Blackstone, KKR, and others to Apollo's core origination-first franchise.
In a worst-case scenario, a decisive break below the $99.56 52-week low would trigger momentum-driven selling and open a new leg lower, with the stock already having suffered a 34.3% maximum drawdown. From the current $110.78, a move to the 52-week low implies roughly -10%, while a retest of the drawdown trough would imply a decline of about -34% from the recent high near $153.29. If mark-to-market losses recur in the retirement segment, the easyJet deal consumes capital without a clear return, and the alternative-manager de-rating persists, the realistic downside is a break below $99.56 toward the low-$90s, or roughly -15% to -20% from here, with the analyst low target of $127 offering no downside protection in that scenario.
FAQ
The most severe risk is earnings volatility from the retirement segment: Q1 2026 produced a $1.906 billion net loss and -$3.24 diluted EPS, dragging trailing EPS to $0.04. Second is the technical downtrend, with the stock 24.4% lower year-to-date, 36.4 points behind the S&P 500, and only 11% above the $99.56 low, where a break could trigger momentum selling against an 8.62-day short ratio. Third is margin compression, with the Q2 2026 operating margin of 23.2% below the 32.3% of Q3 2025 as lower-margin spread income grows. Fourth is balance-sheet intensity, with a 0.78 current ratio and $15.2 billion of Q2 investing outflows funding growth externally.
The 12-month forecast has three scenarios: a 30% probability bull case of $149.40-$173.00 if marks normalize and the multiple re-rates, a 50% probability base case of $127.00-$149.40 as consensus EPS of $13.42 is delivered gradually, and a 20% probability bear case of $99.56-$127.00 if another loss quarter or a break below the 52-week low occurs. The base case is most likely, resting on the assumption that the Q1 2026 mark-to-market loss is not repeated and fee-earning AUM continues to grow from $858 billion. The $149.40 average analyst target sits at the top of the base case, implying the consensus expects the upper end of normalization.
APO looks undervalued on forward earnings and fairly valued on trailing earnings. The 10.4x forward PE is roughly 60% below the 25.9x trailing multiple and near the low end of the 11.8x-50.3x quarterly band over the past two years, while price-to-book at 3.77x is below the 4.3x-5.6x levels seen in mid-2024 through early 2025. The market is paying a discount that implies skepticism about earnings quality and mark-to-market volatility rather than about the $858 billion fee-earning AUM franchise. If consensus EPS of $13.42 is delivered, the current price embeds substantial upside; if mark-to-market losses recur, the trailing multiple is the more honest guide.
From a risk/reward perspective, APO offers 34.9% upside to the $149.40 average analyst target against roughly 10% downside to the $99.56 52-week low, a favorable ratio if the earnings recovery materializes. The 10.4x forward PE on consensus EPS of $13.42 is near the low end of Apollo's two-year range, and the 9.1% free cash flow yield provides a valuation cushion. However, the stock is in an accelerating downtrend (-11.0% over one month) and sits only 11% above its 52-week low, so timing matters. It is a good buy for patient investors who can tolerate a 1.58 beta and wait for a higher low, but not for those who need near-term momentum confirmation.
APO is better suited to a long-term holding period of at least 18-24 months, given the 1.58 beta, the 34.3% max drawdown, and the quarterly earnings volatility that makes short-term timing difficult. The 1.47% dividend yield with a 37.2% payout ratio is modest and does not provide meaningful income support, so the return case rests on multiple re-rating and fee-earning AUM compounding rather than yield. Short-term traders could attempt a bounce off the $99.56 low, but the accelerating downtrend and 8.62-day short ratio make that a high-risk trade. A staged accumulation approach, adding on stabilization above $120, fits the risk profile best.